ACC 2010 schedule: Difference between revisions

Jump to navigation Jump to search
Line 113: Line 113:


===9:00 AM===
===9:00 AM===
*'''Interviewee:''' Robert A. Byrne
*'''Trial:''' Randomized Trial of a Polymer-Free Dual Drug-Eluting Stent versus Polymer-Based Cypher and Endeavor Drug-Eluting Stents - Two-year Clinical and Angiographic Outcomes


===9:30 AM===
===9:30 AM===
*'''Interviewee:''' Robert A. Byrne
*'''Trial:''' Randomized Trial of a Polymer-Free Dual Drug-Eluting Stent versus Polymer-Based Cypher and Endeavor Drug-Eluting Stents - Two-year Clinical and Angiographic Outcomes


===10:00 AM===
===10:00 AM===

Revision as of 22:13, 4 February 2010

Here is the page we will use to coordinate interviews at ACC 2010

Filming location: Atlanta Marriott Downtown 160 Spring Street Atlanta, GA 30303

Filming will occur from Saturday to Tuesday (March 13 - March 16). Dr. Gibson is available to interview during all times listed in black. For all times listed in green, Dr. Gibson is unavailable to conduct the interview. You may, however, go ahead and speak about your topic/present your slides.



Click on Date for Detailed Schedule

Saturday March 13, 2010

Sunday March 14, 2010

Monday March 15, 2010

Tuesday March 16, 2010


Saturday, March 13, 2010

8:30 AM

9:00 AM

  • Interviewee:
  • Trial:

9:30 AM

10:00 AM

  • Interviewee:
  • Trial:

10:30 AM

  • Interviewee:
  • Trial:

11:00 AM

11:30 AM

12:00 PM

12:30 PM

1:00 PM

1:30 PM

2:00 PM

2:30 PM

3:00 PM

3:30 PM

4:00 PM

4:30 PM

Return to top

Sunday March 14, 2010

8:30 AM

9:00 AM

9:30 AM

10:00 AM

10:30 AM

11:00 AM

11:30 AM

12:00 PM

12:30 PM

1:00 PM

1:30 PM

  • Interviewee:
  • Trial:

2:00 PM

  • Interviewee:
  • Trial:

2:30 PM

3:00 PM

3:30 PM

4:00 PM

4:30 PM

Return to top

Monday March 15, 2010

8:30 AM

9:00 AM

  • Interviewee: Robert A. Byrne
  • Trial: Randomized Trial of a Polymer-Free Dual Drug-Eluting Stent versus Polymer-Based Cypher and Endeavor Drug-Eluting Stents - Two-year Clinical and Angiographic Outcomes

9:30 AM

10:00 AM

  • Interviewee: Ted Feldman
  • Trial: Primary Safety and Efficacy Endpoints of the EVEREST II Randomized Clinical Trial

10:30 AM

  • Interviewee: Michael D. Ezekowitz
  • Trial: A Randomized Clinical Trial of Three Doses of a Long-Acting Oral Direct Factor Xa Inhibitor Betrixaban in Patients With Atrial Fibrillation

11:00 AM

  • Interviewee:
  • Trial:

11:30 AM

  • Interviewee:
  • Trial:

12:00 PM

12:30 PM

1:00 PM

1:30 PM

2:00 PM

2:30 PM

3:00 PM

3:30 PM

4:00 PM

4:30 PM

Return to top

Tuesday March 16, 2010

8:30 AM

9:00 AM

9:30 AM

10:00 AM

10:30 AM

11:00 AM

  • Interviewee:
  • Trial:


Return to top